bf/NASDAQ:NTRB_icon.jpeg

NASDAQ:NTRB

Nutriband

  • Stock

6.30

−8.43%

0.00

USD last updated 15/08 02:20:07

Last Close

6.30

14/08 21:27

Market Cap

65.00M

Beta: −0.01

Volume Today

147.63K

Avg: 10.42K

PE Ratio

−4.15

PFCF: −6.01

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other prod...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.5-0.4-0.3-0.2-0.12019-01-302020-09-112022-01-302023-12-122024-09-06

    Revenue (Estimate*)

    500K1M1.50M2M2019-01-302020-09-112022-01-302023-12-122024-09-06

    *Estimate based on analyst consensus